spacer
spacer

PDBsum entry 1tb6

Go to PDB code: 
Top Page protein ligands Protein-protein interface(s) links
Hydrolase/blood clotting PDB id
1tb6
Contents
Protein chains
43 a.a.
259 a.a. *
412 a.a. *
Ligands
NAG-NAG-FUC
GU3-GU2-GU6-GU1-
GU5-GU8-GU9-GU8-
GU9-GU8-GU9-GU8-
GU5-GU0-GU6-GU4
NAG-NAG-BMA-MAN-
MAN
NAG-NAG-BMA
MPD ×8
NAG
Waters ×146
* Residue conservation analysis

References listed in PDB file
Key reference
Title Structure of the antithrombin-Thrombin-Heparin ternary complex reveals the antithrombotic mechanism of heparin.
Authors W.Li, D.J.Johnson, C.T.Esmon, J.A.Huntington.
Ref. Nat Struct Mol Biol, 2004, 11, 857-862. [DOI no: 10.1038/nsmb811]
PubMed id 15311269
Abstract
The maintenance of normal blood flow depends completely on the inhibition of thrombin by antithrombin, a member of the serpin family. Antithrombin circulates at a high concentration, but only becomes capable of efficient thrombin inhibition on interaction with heparin or related glycosaminoglycans. The anticoagulant properties of therapeutic heparin are mediated by its interaction with antithrombin, although the structural basis for this interaction is unclear. Here we present the crystal structure at a resolution of 2.5 A of the ternary complex between antithrombin, thrombin and a heparin mimetic (SR123781). The structure reveals a template mechanism with antithrombin and thrombin bound to the same heparin chain. A notably close contact interface, comprised of extensive active site and exosite interactions, explains, in molecular detail, the basis of the antithrombotic properties of therapeutic heparin.
Figure 1.
Figure 1. Heparin catalysis of thrombin inhibition by antithrombin. (a) The binding of the specific heparin pentasaccharide to antithrombin induces a global conformational change involving the expulsion of the hinge region (circled) of the reactive center loop (RCL, yellow) from the central -sheet A (red), and extension (yellow) of the A and D helices (green and cyan, respectively). The expulsion of the hinge region increases the flexibility of the RCL and liberates the P1 Arg (green ball-and-stick). The flexibility of the C-terminal portion of the RCL (P' side) is limited, despite a three-residue insertion (orange), owing to a tight hydrogen-bonded turn. (b) Stereo representation of the crystal structure of the ternary complex between antithrombin (colored as above), thrombin (magenta) and heparin (ball-and-stick, with blue 2F[o] - F[c] electron density contoured at 1 ). Thrombin is docked toward the heparin-binding site of antithrombin, and makes several exosite interactions. The expulsion of the hinge region is not required to form this complex, but the P' side of the RCL (orange) has been elongated. (c) Density (calculated as in b) of the hinge region of antithrombin in its complex with thrombin and heparin (yellow) reveals the insertion of P15 Gly into -sheet A, and a larger opening between strands 3 and 5A than seen for pentasaccharide-bound antithrombin alone (gray). It has been shown that high-affinity binding is not inconsistent with a native-like hinge conformation, as demonstrated by the structure in PDB entry 1NQ9 (ref. 42) (brown). (d) A comparison of the conformations of the P' region of the RCL of pentasaccharide activated antithrombin (gray) to that of antithrombin in the complex with thrombin and heparin (yellow, oriented as in a and b) reveals the requirement for P' elongation through the breaking of hydrogen bonds.
Figure 3.
Figure 3. Thrombin exosite interactions. (a,b) Thrombin interacts closely with antithrombin by forming exosite interactions in the -loop (a) and the Na^+-binding region (b) (colored as in Fig. 2a). (c) The heparin mimetic (SR123781) used in crystallization is labeled from A on the nonreducing end to P on the reducing end. It is composed of a thrombin-binding site (ABC) and an antithrombin-binding site (LMNOP). The interactions with thrombin and antithrombin are indicated by lines, with solid lines indicating a salt bridge, dashed lines hydrogen bonds, dashed-dotted lines for water-mediated hydrogen bonds, and dotted lines for potential interactions (only for Lys240).
The above figures are reprinted by permission from Macmillan Publishers Ltd: Nat Struct Mol Biol (2004, 11, 857-862) copyright 2004.
PROCHECK
Go to PROCHECK summary
 Headers

 

spacer

spacer